» Articles » PMID: 31391251

A Molecular Switch in Mouse CD1d Modulates Natural Killer T Cell Activation by α-galactosylsphingamides

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2019 Aug 9
PMID 31391251
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Type I natural killer T (NKT) cells are a population of innate like T lymphocytes that rapidly respond to α-GalCer presented by CD1d via the production of both pro- and anti-inflammatory cytokines. While developing novel α-GalCer analogs that were meant to be utilized as potential adjuvants because of their production of pro-inflammatory cytokines (Th1 skewers), we generated α-galactosylsphingamides (αGSA). Surprisingly, αGSAs are not potent antigens despite their strong T-cell receptor (TCR)-binding affinities. Here, using surface plasmon resonance (SPR), antigen presentation assays, and X-ray crystallography (yielding crystal structures of 19 different binary (CD1d-glycolipid) or ternary (CD1d-glycolipid-TCR) complexes at resolutions between 1.67 and 2.85 Å), we characterized the biochemical and structural details of αGSA recognition by murine NKT cells. We identified a molecular switch within murine (m)CD1d that modulates NKT cell activation by αGSAs. We found that the molecular switch involves a hydrogen bond interaction between Tyr-73 of mCD1d and the amide group oxygen of αGSAs. We further established that the length of the acyl chain controls the positioning of the amide group with respect to the molecular switch and works synergistically with Tyr-73 to control NKT cell activity. In conclusion, our findings reveal important mechanistic insights into the presentation and recognition of glycolipids with polar moieties in an otherwise apolar milieu. These observations may inform the development αGSAs as specific NKT cell antagonists to modulate immune responses.

Citing Articles

A Humanized Mouse Model Coupled with Computational Analysis Identifies Potent Glycolipid Agonist of Invariant NKT Cells.

Saavedra-Avila N, Pigni N, Caldwell D, Chena-Becerra F, Intano Jr J, Ng T ACS Chem Biol. 2024; 19(4):926-937.

PMID: 38477945 PMC: 11075374. DOI: 10.1021/acschembio.3c00736.

References
1.
Naidenko O, Maher J, Ernst W, Sakai T, Modlin R, Kronenberg M . Binding and antigen presentation of ceramide-containing glycolipids by soluble mouse and human CD1d molecules. J Exp Med. 1999; 190(8):1069-80. PMC: 2195664. DOI: 10.1084/jem.190.8.1069. View

2.
Smyth M, Crowe N, Pellicci D, Kyparissoudis K, Kelly J, Takeda K . Sequential production of interferon-gamma by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of alpha-galactosylceramide. Blood. 2002; 99(4):1259-66. DOI: 10.1182/blood.v99.4.1259. View

3.
Sidobre S, Naidenko O, Sim B, Gascoigne N, Garcia K, Kronenberg M . The V alpha 14 NKT cell TCR exhibits high-affinity binding to a glycolipid/CD1d complex. J Immunol. 2002; 169(3):1340-8. DOI: 10.4049/jimmunol.169.3.1340. View

4.
Lovell S, Davis I, Arendall 3rd W, de Bakker P, Word J, Prisant M . Structure validation by Calpha geometry: phi,psi and Cbeta deviation. Proteins. 2003; 50(3):437-50. DOI: 10.1002/prot.10286. View

5.
Skold M, Behar S . Role of CD1d-restricted NKT cells in microbial immunity. Infect Immun. 2003; 71(10):5447-55. PMC: 201095. DOI: 10.1128/IAI.71.10.5447-5455.2003. View